Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Andrew T. Dufresne

ID: 1b83b284-2619-30fb-68c4

/

Claimed Record

/

Organization: Perkins Coie LLP

Senator Tillis Asks the PTO to Reconsider Fintiv Factor Two

Life Science Legal Report · November 4, 2021

How reliable are trial dates relied on by the PTAB in the Fintiv analysis?

Life Science Legal Report · October 29, 2021

What Qualifies as a Good “Good Cause” When Responding to a Patent Owner’s Preliminary Response?

Life Science Legal Report · March 12, 2021

Federal Circuit confirms that the PTAB can consider the patent eligibility of substitute claims proposed during an IPR

Life Science Legal Report · July 24, 2020

USPTO announces proposed rule changes on presumptions at institution and briefing permitted for patent owners during trial, among others

Life Science Legal Report · May 29, 2020

Previous

12 3

Next

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Publishing Record

Publisher Since 2018

Total Articles 15

Most Recent November 4, 2021

Cite This Author

Andrew T. Dufresne, Perkins Coie LLP

LexBlog Author ID:

1b83b284-2619-30fb-68c4

www.lexblog.com/author/adufresne

Contact

FirmPerkins Coie LLP

EmailADufresne@perkinscoie.com

BlogLife Science Legal Report

LinkedInView Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog